Amagma Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Amagma Therapeutics's estimated annual revenue is currently $2.8M per year.
- Amagma Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Amagma Therapeutics has 18 Employees.
- Amagma Therapeutics grew their employee count by 13% last year.
Amagma Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Biologics | Reveal Email/Phone |
2 | Senior Scientist, Protein Biochemistry | Reveal Email/Phone |
3 | Scientist | Reveal Email/Phone |
Amagma Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Amagma Therapeutics?
Amagma Therapeutics is a startup biotechnology company founded by proven serial entrepreneurs including Prof. Tillman Gerngross and Prof. Leonard Zon. Amagma scientists are working on the discovery and development of antibody therapeutics against inflammatory diseases (with a focus on GI disorders) which have proven intractable by other approaches. Amagma is based in Waltham, Massachusetts, and funded by private investors including Polaris Partners.
keywords:N/AN/A
Total Funding
18
Number of Employees
$2.8M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.6M | 18 | -5% | N/A |
#2 | $1.6M | 18 | N/A | N/A |
#3 | $1.4M | 18 | -65% | $23.5M |
#4 | $3.5M | 18 | -10% | $19.5M |
#5 | $1.8M | 18 | 6% | $82.4M |